Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries.

Ouwerkerk W, Teng TK, Tromp J, Tay WT, Cleland JG, van Veldhuisen DJ, Dickstein K, Ng LL, Lang CC, Anker SD, Zannad F, Hung CL, Sawhney JPS, Naik A, Shimizu W, Hagiwara N, Wander GS, Anand I, Richards AM, Voors AA, Lam CSP

Open source

DOI: 10.1002/ejhf.1869
Published: 2020 Aug
Container: European journal of heart failure
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/ejhf.1869,
  title = {Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries.},
  author = {Ouwerkerk W and Teng TK and Tromp J and Tay WT and Cleland JG and van Veldhuisen DJ and Dickstein K and Ng LL and Lang CC and Anker SD and Zannad F and Hung CL and Sawhney JPS and Naik A and Shimizu W and Hagiwara N and Wander GS and Anand I and Richards AM and Voors AA and Lam CSP},
  year = {2020},
  journal = {European journal of heart failure},
  doi = {10.1002/ejhf.1869},
  url = {https://doi.org/10.1002/ejhf.1869}
}

RIS

TY  - JOUR
TI  - Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries.
AU  - Ouwerkerk W
AU  - Teng TK
AU  - Tromp J
AU  - Tay WT
AU  - Cleland JG
AU  - van Veldhuisen DJ
AU  - Dickstein K
AU  - Ng LL
AU  - Lang CC
AU  - Anker SD
AU  - Zannad F
AU  - Hung CL
AU  - Sawhney JPS
AU  - Naik A
AU  - Shimizu W
AU  - Hagiwara N
AU  - Wander GS
AU  - Anand I
AU  - Richards AM
AU  - Voors AA
AU  - Lam CSP
PY  - 2020
JO  - European journal of heart failure
DO  - 10.1002/ejhf.1869
UR  - https://doi.org/10.1002/ejhf.1869
ER  -

APA

W, O., TK, T., J, T., WT, T., JG, C., DJ, V. V., K, D., LL, N., CC, L., SD, A., F, Z., CL, H., JPS, S., A, N., W, S., N, H., GS, W., I, A., AM, R., AA, V., & CSP, L. (2020). Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries.. European journal of heart failure. https://doi.org/10.1002/ejhf.1869

Source records

pubmed · retrieved 2026-09-26T05:01:18.011Z